{
  "requested_url": "http://feeds.reuters.com/reuters/healthNews",
  "fetched_at": "2018-02-18T22:20:19.305409",
  "status_code": 200,
  "response_text": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\r\n<?xml-stylesheet type=\"text/xsl\" media=\"screen\" href=\"/~d/styles/rss2full.xsl\"?><?xml-stylesheet type=\"text/css\" media=\"screen\" href=\"http://feeds.reuters.com/~d/styles/itemcontent.css\"?><rss xmlns:feedburner=\"http://rssnamespace.org/feedburner/ext/1.0\" version=\"2.0\">\r\n<channel>\r\n<title>Reuters: Health News</title>\r\n<link>http://www.reuters.com</link>\r\n<description>Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks.  Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.</description>\r\n<image>\r\n\t<title>Reuters News</title>\r\n\t<width>120</width>\r\n\t<height>35</height>\r\n\t<link>http://www.reuters.com</link>\r\n\t<url>http://www.reuters.com/resources_v2/images/reuters125.png</url>\r\n</image>\r\n<language>en-us</language>\r\n<lastBuildDate>Sun, 18 Feb 2018 11:39:21 -0500</lastBuildDate>\r\n<copyright>All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. \u00a9 Reuters 2018</copyright>\r\n<atom10:link xmlns:atom10=\"http://www.w3.org/2005/Atom\" rel=\"self\" type=\"application/rss+xml\" href=\"http://feeds.reuters.com/reuters/healthNews\" /><feedburner:info uri=\"reuters/healthnews\" /><atom10:link xmlns:atom10=\"http://www.w3.org/2005/Atom\" rel=\"hub\" href=\"http://pubsubhubbub.appspot.com/\" /><feedburner:feedFlare href=\"https://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews\" src=\"http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif\">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href=\"http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews\" src=\"http://www.newsgator.com/images/ngsub1.gif\">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href=\"http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews\" src=\"http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif\">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href=\"http://www.bloglines.com/sub/http://feeds.reuters.com/reuters/healthNews\" src=\"http://www.bloglines.com/images/sub_modern11.gif\">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href=\"http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews\" src=\"//www.netvibes.com/img/add2netvibes.gif\">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href=\"http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews\" src=\"http://buttons.googlesyndication.com/fusion/add.gif\">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href=\"http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.reuters.com%2Freuters%2FhealthNews\" src=\"http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif\">Subscribe with Pageflakes</feedburner:feedFlare><item>\r\n\t\t<title>AstraZeneca's immunotherapy drug wins key lung cancer approval</title>\r\n\r\n\t\t<description>LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=t0KsI_CnOdA:qYbKDs7eyPg:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=t0KsI_CnOdA:qYbKDs7eyPg:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=t0KsI_CnOdA:qYbKDs7eyPg:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=t0KsI_CnOdA:qYbKDs7eyPg:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=t0KsI_CnOdA:qYbKDs7eyPg:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/t0KsI_CnOdA\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/t0KsI_CnOdA/astrazenecas-immunotherapy-drug-wins-key-lung-cancer-approval-idUSKCN1G02IA</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-astrazeneca-fda/astrazenecas-immunotherapy-drug-wins-key-lung-cancer-approval-idUSKCN1G02IA?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Sat, 17 Feb 2018 05:26:09 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-astrazeneca-fda/astrazenecas-immunotherapy-drug-wins-key-lung-cancer-approval-idUSKCN1G02IA?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict</title>\r\n\r\n\t\t<description>(Reuters) - A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck &amp; Co Inc.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=MCgeVYCpFcw:TVCvVcuKtcw:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=MCgeVYCpFcw:TVCvVcuKtcw:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=MCgeVYCpFcw:TVCvVcuKtcw:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=MCgeVYCpFcw:TVCvVcuKtcw:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=MCgeVYCpFcw:TVCvVcuKtcw:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/MCgeVYCpFcw\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/MCgeVYCpFcw/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict-idUSKCN1G10MH</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-gilead-sciences-lawsuit/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict-idUSKCN1G10MH?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Sat, 17 Feb 2018 12:20:05 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-gilead-sciences-lawsuit/gilead-wins-reversal-of-2-54-billion-hepatitis-c-drug-patent-verdict-idUSKCN1G10MH?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Shares of Apricus tank after FDA declines to OK erectile dysfunction cream</title>\r\n\r\n\t\t<description>(Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=xYR98ggoUcg:Y9FYCeVPzws:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=xYR98ggoUcg:Y9FYCeVPzws:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=xYR98ggoUcg:Y9FYCeVPzws:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=xYR98ggoUcg:Y9FYCeVPzws:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=xYR98ggoUcg:Y9FYCeVPzws:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/xYR98ggoUcg\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/xYR98ggoUcg/shares-of-apricus-tank-after-fda-declines-to-ok-erectile-dysfunction-cream-idUSKCN1G016W</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-apricus-fda/shares-of-apricus-tank-after-fda-declines-to-ok-erectile-dysfunction-cream-idUSKCN1G016W?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 09:00:21 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-apricus-fda/shares-of-apricus-tank-after-fda-declines-to-ok-erectile-dysfunction-cream-idUSKCN1G016W?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Novartis readies to auction U.S. generic pills business: sources</title>\r\n\r\n\t\t<description>(Reuters) - Switzerland's Novartis AG  is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=x39bAH8NJWo:g7tbgk1278Y:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=x39bAH8NJWo:g7tbgk1278Y:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=x39bAH8NJWo:g7tbgk1278Y:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=x39bAH8NJWo:g7tbgk1278Y:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=x39bAH8NJWo:g7tbgk1278Y:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/x39bAH8NJWo\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/x39bAH8NJWo/novartis-readies-to-auction-u-s-generic-pills-business-sources-idUSKCN1G01SW</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-novartis-genericdrugs/novartis-readies-to-auction-u-s-generic-pills-business-sources-idUSKCN1G01SW?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 12:10:18 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-novartis-genericdrugs/novartis-readies-to-auction-u-s-generic-pills-business-sources-idUSKCN1G01SW?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>U.S. faces shortage of developmental and behavioral pediatrics specialists</title>\r\n\r\n\t\t<description>(Reuters Health) - A shortage of clinicians specializing in pediatric behavioral and developmental disorders is translating into long wait times for new patient appointments amid surging demand, a new study suggests.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=vhwxL4cIdjs:dtyBwzbD0b0:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=vhwxL4cIdjs:dtyBwzbD0b0:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=vhwxL4cIdjs:dtyBwzbD0b0:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=vhwxL4cIdjs:dtyBwzbD0b0:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=vhwxL4cIdjs:dtyBwzbD0b0:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/vhwxL4cIdjs\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/vhwxL4cIdjs/u-s-faces-shortage-of-developmental-and-behavioral-pediatrics-specialists-idUSKCN1G02KO</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-health-pediatrics-doctor-shortage/u-s-faces-shortage-of-developmental-and-behavioral-pediatrics-specialists-idUSKCN1G02KO?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 18:30:41 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-health-pediatrics-doctor-shortage/u-s-faces-shortage-of-developmental-and-behavioral-pediatrics-specialists-idUSKCN1G02KO?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Fear of federal law may prevent gun retailers from storing firearms</title>\r\n\r\n\t\t<description>(Reuters Health) - What if someone who lived with the young man who unleashed one of the deadliest school shootings in U.S. history this week had been concerned that he might harm himself or others and removed his AR-15 rifle from his home?&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=ZcgDMyBFIAc:325i3A7vWiA:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=ZcgDMyBFIAc:325i3A7vWiA:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=ZcgDMyBFIAc:325i3A7vWiA:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=ZcgDMyBFIAc:325i3A7vWiA:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=ZcgDMyBFIAc:325i3A7vWiA:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/ZcgDMyBFIAc\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/ZcgDMyBFIAc/fear-of-federal-law-may-prevent-gun-retailers-from-storing-firearms-idUSKCN1G027Y</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-health-guns-storage-suicide/fear-of-federal-law-may-prevent-gun-retailers-from-storing-firearms-idUSKCN1G027Y?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 14:34:04 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-health-guns-storage-suicide/fear-of-federal-law-may-prevent-gun-retailers-from-storing-firearms-idUSKCN1G027Y?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Hospitalized older adults less often tested for flu</title>\r\n\r\n\t\t<description>(Reuters Health) - Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=Br6Glqg_DQM:ta_9AHY5US4:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=Br6Glqg_DQM:ta_9AHY5US4:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=Br6Glqg_DQM:ta_9AHY5US4:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=Br6Glqg_DQM:ta_9AHY5US4:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=Br6Glqg_DQM:ta_9AHY5US4:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/Br6Glqg_DQM\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/Br6Glqg_DQM/hospitalized-older-adults-less-often-tested-for-flu-idUSKCN1G028G</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/uk-health-flu-elderly/hospitalized-older-adults-less-often-tested-for-flu-idUSKCN1G028G?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 14:39:34 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/uk-health-flu-elderly/hospitalized-older-adults-less-often-tested-for-flu-idUSKCN1G028G?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>In-person license renewal may reduce crashes involving people with dementia</title>\r\n\r\n\t\t<description>Reuters Health - Older adults with dementia may be less likely to get in car crashes when they\u2019re required to renew their driver\u2019s licenses in person, a U.S. study suggests.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=Zh-TavCB5dA:LRJ6Z6sS_Uk:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=Zh-TavCB5dA:LRJ6Z6sS_Uk:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=Zh-TavCB5dA:LRJ6Z6sS_Uk:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=Zh-TavCB5dA:LRJ6Z6sS_Uk:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=Zh-TavCB5dA:LRJ6Z6sS_Uk:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/Zh-TavCB5dA\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/Zh-TavCB5dA/in-person-license-renewal-may-reduce-crashes-involving-people-with-dementia-idUSKCN1G01TA</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-health-dementia-driver-license/in-person-license-renewal-may-reduce-crashes-involving-people-with-dementia-idUSKCN1G01TA?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 11:11:04 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-health-dementia-driver-license/in-person-license-renewal-may-reduce-crashes-involving-people-with-dementia-idUSKCN1G01TA?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Pot Pharm: Booming Canada weed sector plots next-wave medicines</title>\r\n\r\n\t\t<description>TORONTO (Reuters) - Canopy Growth Corp, one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=SW0bXOBQcNY:7cXhYtB6WV8:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=SW0bXOBQcNY:7cXhYtB6WV8:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=SW0bXOBQcNY:7cXhYtB6WV8:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=SW0bXOBQcNY:7cXhYtB6WV8:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=SW0bXOBQcNY:7cXhYtB6WV8:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/SW0bXOBQcNY\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/SW0bXOBQcNY/pot-pharm-booming-canada-weed-sector-plots-next-wave-medicines-idUSKCN1G00EK</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-canada-marijuana-innovation/pot-pharm-booming-canada-weed-sector-plots-next-wave-medicines-idUSKCN1G00EK?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Fri, 16 Feb 2018 06:37:09 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-canada-marijuana-innovation/pot-pharm-booming-canada-weed-sector-plots-next-wave-medicines-idUSKCN1G00EK?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n<item>\r\n\t\t<title>Swiss skiers first athletes hit by norovirus at Games</title>\r\n\r\n\t\t<description>PYEONGCHANG, South Korea (Reuters) - Two Swiss freestyle skiers are the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olympic team confirmed on Friday.&lt;div class=\"feedflare\"&gt;\r\n&lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=qzP0ybnRR5E:-mH2eOHxtdw:yIl2AUoC8zA\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=qzP0ybnRR5E:-mH2eOHxtdw:F7zBnMyn0Lo\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=qzP0ybnRR5E:-mH2eOHxtdw:F7zBnMyn0Lo\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt; &lt;a href=\"http://feeds.reuters.com/~ff/reuters/healthNews?a=qzP0ybnRR5E:-mH2eOHxtdw:V_sGLiPBpWU\"&gt;&lt;img src=\"http://feeds.feedburner.com/~ff/reuters/healthNews?i=qzP0ybnRR5E:-mH2eOHxtdw:V_sGLiPBpWU\" border=\"0\"&gt;&lt;/img&gt;&lt;/a&gt;\r\n&lt;/div&gt;&lt;img src=\"http://feeds.feedburner.com/~r/reuters/healthNews/~4/qzP0ybnRR5E\" height=\"1\" width=\"1\" alt=\"\"/&gt;</description>\r\n\r\n\t\t<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/qzP0ybnRR5E/swiss-skiers-first-athletes-hit-by-norovirus-at-games-idUSKCN1G009H</link>\r\n        <guid isPermaLink=\"false\">http://www.reuters.com/article/us-olympics-2018-virus/swiss-skiers-first-athletes-hit-by-norovirus-at-games-idUSKCN1G009H?feedType=RSS&amp;feedName=healthNews</guid>\r\n        <category>healthNews</category>\r\n\t\t<pubDate>Thu, 15 Feb 2018 23:45:07 -0500</pubDate>\r\n\t\t<feedburner:origLink>http://www.reuters.com/article/us-olympics-2018-virus/swiss-skiers-first-athletes-hit-by-norovirus-at-games-idUSKCN1G009H?feedType=RSS&amp;feedName=healthNews</feedburner:origLink></item>\r\n</channel>\r\n</rss>\r\n",
  "headers": {
    "Transfer-Encoding": "chunked",
    "ETag": "wR5MAr789Ebq9lMfWPjyLNkjRVM",
    "Content-Type": "text/xml; charset=UTF-8",
    "Cache-Control": "private, max-age=0",
    "Server": "GSE",
    "X-XSS-Protection": "1; mode=block",
    "Last-Modified": "Sun, 18 Feb 2018 16:45:49 GMT",
    "Content-Encoding": "gzip",
    "Date": "Sun, 18 Feb 2018 16:50:19 GMT",
    "X-Content-Type-Options": "nosniff",
    "Expires": "Sun, 18 Feb 2018 16:50:19 GMT"
  },
  "response_url": "http://feeds.reuters.com/reuters/healthNews"
}